Theriva Biologics, Inc. (TOVX)
0.196
+0.01
(+3.16%)
USD |
NYAM |
Oct 23, 16:00
0.1916
0.00 (0.00%)
After-Hours: 20:00
Theriva Biologics EPS Diluted (Quarterly) : -0.0701 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0701 |
| March 31, 2026 | -0.0498 |
| December 31, 2025 | -0.0982 |
| September 30, 2025 | -0.4507 |
| June 30, 2025 | -1.934 |
| March 31, 2025 | -1.554 |
| December 31, 2024 | -1.598 |
| September 30, 2024 | -6.811 |
| June 30, 2024 | -10.72 |
| March 31, 2024 | -7.53 |
| December 31, 2023 | -7.996 |
| September 30, 2023 | -4.845 |
| June 30, 2023 | -8.380 |
| March 31, 2023 | -7.402 |
| December 31, 2022 | -8.886 |
| September 30, 2022 | -7.621 |
| June 30, 2022 | -7.065 |
| March 31, 2022 | -7.73 |
| December 31, 2021 | -9.965 |
| September 30, 2021 | -6.198 |
| June 30, 2021 | -6.05 |
| March 31, 2021 | -31.55 |
| December 31, 2020 | -36.21 |
| September 30, 2020 | -34.62 |
| June 30, 2020 | -45.12 |
| Date | Value |
|---|---|
| March 31, 2020 | -50.16 |
| December 31, 2019 | -46.74 |
| September 30, 2019 | -78.14 |
| June 30, 2019 | -56.32 |
| March 31, 2019 | -63.41 |
| December 31, 2018 | -277.41 |
| September 30, 2018 | -232.17 |
| June 30, 2018 | -289.01 |
| March 31, 2018 | -161.61 |
| December 31, 2017 | 175.00 |
| September 30, 2017 | -1225.00 |
| June 30, 2017 | -262.50 |
| March 31, 2017 | -175.00 |
| December 31, 2016 | -175.00 |
| September 30, 2016 | -787.50 |
| June 30, 2016 | -875.00 |
| March 31, 2016 | -1050.00 |
| December 31, 2015 | -1050.00 |
| September 30, 2015 | -1050.00 |
| June 30, 2015 | -1662.50 |
| March 31, 2015 | -1487.50 |
| December 31, 2014 | -875.00 |
| September 30, 2014 | -700.00 |
| June 30, 2014 | -700.00 |
| March 31, 2014 | -612.50 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.217M |
| Total Expenses (Quarterly) | 3.217M |
| Enterprise Value | 1.211M |
| Earnings Yield | -341.2% |
| Normalized Earnings Yield | -348.72 |